By David Tuller, DrPH.
I know folks are eager to hear more about what I’m learning in Australia. I’m finding it challenging to have meetings, prepare for talks, conduct interviews, promote the crowdfunding, keep up with my BMJ Open correspondence, and also write posts about what’s happening here. It will take a bit of time to catch up.
But I do want to provide at least some initial information about the role of Professor Andrew Lloyd of the University of New South Wales. Australian patients know that Professor Lloyd is the country’s most prominent proponent of the CBT/GET paradigm for treatment of what he prefers to call chronic fatigue syndrome. As an infectious disease doctor, he led the well-known Dubbo Infection Outcomes Study, with the main results published in The BMJ in 2006. The research documented that 11 percent of those experiencing a variety of acute infectious diseases progressed to a prolonged illness that met the Fukuda criteria for chronic fatigue syndrome.
I conducted a Skype interview with Professor Lloyd from Canberra on Friday, March 23rd, because he wasn’t available to see me in person the following week in Sydney. Despite my dysfunctional relationship with technology, I managed to figure out how to download an app to record our call. Unfortunately, I lost my internet connection before I got to everything I wanted to ask, so he later answered a few questions via e-mail.
To read the rest of this story, click on the link below: